Stryker Ronda E's Form 4/A amendment
AmendedStryker Corp (SYK) · filed Feb 4, 2025
- Accession no.
- 0000310764-25-000010
- Filed
- Feb 4, 2025
- Trade date
- Jan 31, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Feb 3, 2025
This filing lists 7 non-derivative transactions. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $92.7M. It was filed 4 days after the trade.
This amendment restates part of 0000310764-25-000008 (filed Feb 3, 2025). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stryker Ronda ECIK 0001242914 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Common Stock | SSaleDisposed | −96,728 | $390.89F2 | −$37,810,007.92 | 3,746,739 | Indirect | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −38,802 | $391.89F3 | −$15,206,115.78 | 3,707,937 | Indirect | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −7,462 | $392.69F4 | −$2,930,252.78 | 3,700,475 | Indirect | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −18,283 | $393.97F5 | −$7,202,953.51 | 3,682,192 | Indirect | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −51,454 | $394.85F6 | −$20,316,611.9 | 3,630,738 | Indirect | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −11,058 | $395.90F7 | −$4,377,862.2 | 3,619,680 | Indirect | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −12,213 | $396.69F8 | −$4,844,774.97 | 3,607,467 | Indirect |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000310764-25-000008 (filed Feb 3, 2025).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Common Stock | MOption exerciseAcquired | +3,795 | $93.06 | +$353,162.7 | 7,735 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Common Stock | MOption exerciseDisposed | −3,795 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025.
- F2
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $390.39 to $391.38, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $391.385 to $392.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $392.38 to $393.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $393.38 to $394.375, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $394.38 to $395.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $395.39 to $396.385, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $396.39 to $397.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.